CTN014

N/A

Report date: 2024/12/05 13:33:45

Base Information

Drug NameCTN014
Drug Alias NameCTN014CTN-014
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1Anti-EGFRvIII
TargetsEpidermal growth factor receptor erbB1Epidermal growth factor receptor variant III
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentenaire Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCentenaire Biosciences Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A